KEYAMED NA INC.

 KEYAMED NA INC. contact information is shown below
Owner:KEYAMED NA INC.
Owner Address:107 SPRING STREET SEATTLE WA 98104
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byKEYAMED NA INC.

Brand:

CURA

Description:

Computer software for use in medical diagnostics using medical image analysis, medical records analysis, and bioinformatics analysis supporting clinicians and researchers in fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; computer software for the analysis of medical data, namely, genomics data, for use in identifying and predicting actionable biomarkers, neoantigens, and molecular data for developing paired diagnostics and therapeutics in the fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; computer software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; computer software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; computer software for detecting and predicting neoantigens and peptides for immunotherapy development;The English translation of CURA in the mark is CARE.;Performing medical testing for diagnostic purposes, in particular for diagnostic imaging, including x- rays, computed tomography, magnetic resonance imaging (MRI) and other modalities; performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for medical diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine;Providing software as a service (SaaS) services featuring software for use in medical diagnostics using medical image analysis, medical records analysis, and bioinformatics analysis supporting clinicians and researchers in fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; providing software as a service (SaaS) services featuring software for the analysis of medical data, namely, genomics data for use in identifying and predicting actionable biomarkers, neoantigens, and molecular data for developing paired diagnostics and therapeutics in the fields of radiology, cardiology, oncology, pulmonology, neurology, hematology, endocrinology, otolaryngology, gynecology, obstetrics, urology, orthopedics, ophthalmology, pathology, pediatrics, physical medicine, surgery, emergency medicine, medical genetics and genomics, dermatology, family medicine, internal medicine, colorectal medicine, psychiatry, allergy and immunology, and preventive medicine; providing software as a service (SaaS) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) services featuring software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; providing software as a service (SaaS) services featuring software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes, in particular for detecting and predicting significance of neoantigens and peptides on cells relevant to immunotherapy development;

Category: COMPUTER SOFTWARE USE
Brand:

CURARAD

Description:

Providing software as a service (SaaS) services featuring software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) services featuring software for the analysis of medical data, namely, medical imaging data, health care data, health records, medical records, and genomic data for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, analyzing medical diagnostic data, analyzing molecular medicine data, analyzing precision medicine data, and structural and functional analysis of genomes; providing software as a service (SaaS) services featuring software for the analysis of genomic data for use in tracking variation and mutation of pathogens; providing software as a service (SaaS) services featuring software for determining and predicting patterns in data, namely, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factor data; providing software as a service (SaaS) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) services featuring software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; research, development, testing, and deployment of immunotherapy drugs all being pharmaceutical drug development services; Platform as a service (PaaS) featuring computer software platforms for providing clinical decision support for patient care; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data;

Category: PROVIDING SOFTWARE AS SERVICE